Pregnancy rates and outcomes amongst women with cystic fibrosis in the UK : comparisons with the general population before and after the introduction of disease modifying treatment, 2003-17
| dc.contributor.author | Esan, Oluwaseun | |
| dc.contributor.author | Schlüter, Daniela K. | |
| dc.contributor.author | Phillips, Rhiannon | |
| dc.contributor.author | Cosgriff, Rebecca | |
| dc.contributor.author | Paranjothy, Shantini | |
| dc.contributor.author | Williams, Denitza | |
| dc.contributor.author | Norman, Rachel | |
| dc.contributor.author | Carr, Siobhán B | |
| dc.contributor.author | Duckers, Jamie | |
| dc.contributor.author | Taylor-Robinson, David | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en | 
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Health Data Science | en | 
| dc.date.accessioned | 2022-03-22T16:59:01Z | |
| dc.date.available | 2022-03-22T16:59:01Z | |
| dc.date.issued | 2022-04 | |
| dc.description | Acknowledgements We thank the UK CF Registry team and the UK CF centres and clinics for submitting data to the Registry. Special thanks to the people with cystic fibrosis and their families who have agreed for their UK CF Registry data to be used for research. Funding The study was funded by a Welsh Government Research for Patient and Public Benefit grant. The funder was not involved in the study design, data collection, data analysis, data interpretation or the writing of the report. DT-R is funded by the MRC on a Clinician Scientist Fellowship (MR/P008577/1). | en | 
| dc.description.status | Peer reviewed | en | 
| dc.format.extent | 9 | |
| dc.format.extent | 11139101 | |
| dc.format.extent | 619115 | |
| dc.identifier | 201078165 | |
| dc.identifier | b3088fcb-fb41-4655-8c33-8c4c042b1ea9 | |
| dc.identifier.citation | Esan, O, Schlüter, D K, Phillips, R, Cosgriff, R, Paranjothy, S, Williams, D, Norman, R, Carr, S B, Duckers, J & Taylor-Robinson, D 2022, 'Pregnancy rates and outcomes amongst women with cystic fibrosis in the UK : comparisons with the general population before and after the introduction of disease modifying treatment, 2003-17', BJOG-An International Journal of Obstetrics and Gynaecology, vol. 129, no. 5, pp. 743-751. https://doi.org/10.22541/au.162182734.44469184/v1, https://doi.org/10.1111/1471-0528.16957 | en | 
| dc.identifier.doi | 10.22541/au.162182734.44469184/v1 | |
| dc.identifier.iss | 5 | en | 
| dc.identifier.issn | 1470-0328 | |
| dc.identifier.other | SCOPUS: 85118552569 | |
| dc.identifier.other | ORCID: /0000-0002-0528-3121/work/110275483 | |
| dc.identifier.uri | https://hdl.handle.net/2164/18284 | |
| dc.identifier.vol | 129 | en | 
| dc.language.iso | eng | |
| dc.relation.ispartof | BJOG-An International Journal of Obstetrics and Gynaecology | en | 
| dc.subject | Cystic fibrosis | en | 
| dc.subject | Pregnancy | en | 
| dc.subject | Epidemiology | en | 
| dc.subject | cystic fibrosis transmembrane conductance regulator modulator | en | 
| dc.subject | ivacaftor epidemiology | en | 
| dc.subject | R Medicine | en | 
| dc.subject | Medical Research Council (MRC) | en | 
| dc.subject | MR/P008577/1 | en | 
| dc.subject | Supplementary Data | en | 
| dc.subject.lcc | R | en | 
| dc.title | Pregnancy rates and outcomes amongst women with cystic fibrosis in the UK : comparisons with the general population before and after the introduction of disease modifying treatment, 2003-17 | en | 
| dc.type | Journal article | en | 
